Cargando…

Evaluating the impact of COVID-19 on rare disease support groups

OBJECTIVES: The impact of the current COVID-19 pandemic has been felt worldwide. Many vulnerable populations rely heavily on peer support provided by individual or collaborative groups. This study aimed to evaluate the impact of COVID-19 on groups supporting patients with a rare disease(s). Anecdota...

Descripción completa

Detalles Bibliográficos
Autores principales: McMullan, Julie, Crowe, Ashleen L., Bailie, Caitlin, McKnight, Amy Jayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100734/
https://www.ncbi.nlm.nih.gov/pubmed/33957984
http://dx.doi.org/10.1186/s13104-021-05579-8
_version_ 1783688844651003904
author McMullan, Julie
Crowe, Ashleen L.
Bailie, Caitlin
McKnight, Amy Jayne
author_facet McMullan, Julie
Crowe, Ashleen L.
Bailie, Caitlin
McKnight, Amy Jayne
author_sort McMullan, Julie
collection PubMed
description OBJECTIVES: The impact of the current COVID-19 pandemic has been felt worldwide. Many vulnerable populations rely heavily on peer support provided by individual or collaborative groups. This study aimed to evaluate the impact of COVID-19 on groups supporting patients with a rare disease(s). Anecdotally the current pandemic significantly changed the way in which these groups operate and the services they can provide. DATA DESCRIPTION: A targeted survey was conducted online with rare disease individual or collaborative groups. The results of the survey highlight the challenges individual and collaborative groups are facing during this pandemic and help to identify what support should be put in place to enable them to sustain their much-valued service through these trialing times. Groups have experienced an increase in calls to their helplines as well as followers to their websites and social media feeds. Groups are no longer meeting in person and so online meetings, webinars and zoom chats have become a regular occurrence. Fundraising was highlighted as an area of concern for such groups. It is hoped that this data might be used to highlight the support individual and collaborative groups require while also raising awareness of the value they bring to many.
format Online
Article
Text
id pubmed-8100734
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81007342021-05-06 Evaluating the impact of COVID-19 on rare disease support groups McMullan, Julie Crowe, Ashleen L. Bailie, Caitlin McKnight, Amy Jayne BMC Res Notes Data Note OBJECTIVES: The impact of the current COVID-19 pandemic has been felt worldwide. Many vulnerable populations rely heavily on peer support provided by individual or collaborative groups. This study aimed to evaluate the impact of COVID-19 on groups supporting patients with a rare disease(s). Anecdotally the current pandemic significantly changed the way in which these groups operate and the services they can provide. DATA DESCRIPTION: A targeted survey was conducted online with rare disease individual or collaborative groups. The results of the survey highlight the challenges individual and collaborative groups are facing during this pandemic and help to identify what support should be put in place to enable them to sustain their much-valued service through these trialing times. Groups have experienced an increase in calls to their helplines as well as followers to their websites and social media feeds. Groups are no longer meeting in person and so online meetings, webinars and zoom chats have become a regular occurrence. Fundraising was highlighted as an area of concern for such groups. It is hoped that this data might be used to highlight the support individual and collaborative groups require while also raising awareness of the value they bring to many. BioMed Central 2021-05-06 /pmc/articles/PMC8100734/ /pubmed/33957984 http://dx.doi.org/10.1186/s13104-021-05579-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Data Note
McMullan, Julie
Crowe, Ashleen L.
Bailie, Caitlin
McKnight, Amy Jayne
Evaluating the impact of COVID-19 on rare disease support groups
title Evaluating the impact of COVID-19 on rare disease support groups
title_full Evaluating the impact of COVID-19 on rare disease support groups
title_fullStr Evaluating the impact of COVID-19 on rare disease support groups
title_full_unstemmed Evaluating the impact of COVID-19 on rare disease support groups
title_short Evaluating the impact of COVID-19 on rare disease support groups
title_sort evaluating the impact of covid-19 on rare disease support groups
topic Data Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100734/
https://www.ncbi.nlm.nih.gov/pubmed/33957984
http://dx.doi.org/10.1186/s13104-021-05579-8
work_keys_str_mv AT mcmullanjulie evaluatingtheimpactofcovid19onrarediseasesupportgroups
AT croweashleenl evaluatingtheimpactofcovid19onrarediseasesupportgroups
AT bailiecaitlin evaluatingtheimpactofcovid19onrarediseasesupportgroups
AT mcknightamyjayne evaluatingtheimpactofcovid19onrarediseasesupportgroups